Unknown

Dataset Information

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.


ABSTRACT: Adoptive immunotherapy retargeting T cells to CD19 via a chimeric antigen receptor (CAR) is an investigational treatment capable of inducing complete tumor regression of B-cell malignancies when there is sustained survival of infused cells. T-memory stem cells (TSCM) retain superior potential for long-lived persistence, but challenges exist in manufacturing this T-cell subset because they are rare among circulating lymphocytes. We report a clinically relevant approach to generating CAR+ T cells with preserved TSCM potential using the Sleeping Beauty platform. Because IL-15 is fundamental to T-cell memory, we incorporated its costimulatory properties by coexpressing CAR with a membrane-bound chimeric IL-15 (mbIL15). The mbIL15-CAR T cells signaled through si

SUBMITTER: Hurton LV 

PROVIDER: S-EPMC5137758 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature